Hualan Biological Engineering Inc
SZSE:002007

Watchlist Manager
Hualan Biological Engineering Inc Logo
Hualan Biological Engineering Inc
SZSE:002007
Watchlist
Price: 17.4 CNY -2.36% Market Closed
Market Cap: 31.7B CNY
Have any thoughts about
Hualan Biological Engineering Inc?
Write Note

Hualan Biological Engineering Inc
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Hualan Biological Engineering Inc
Pre-Tax Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
Hualan Biological Engineering Inc
SZSE:002007
Pre-Tax Income
ÂĄ1.7B
CAGR 3-Years
-8%
CAGR 5-Years
0%
CAGR 10-Years
10%
Beigene Ltd
HKEX:6160
Pre-Tax Income
-ÂĄ6.2B
CAGR 3-Years
18%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Pre-Tax Income
-ÂĄ1.3B
CAGR 3-Years
-1%
CAGR 5-Years
28%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Pre-Tax Income
ÂĄ1.4B
CAGR 3-Years
22%
CAGR 5-Years
37%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Pre-Tax Income
ÂĄ4.2B
CAGR 3-Years
-27%
CAGR 5-Years
11%
CAGR 10-Years
39%
Imeik Technology Development Co Ltd
SZSE:300896
Pre-Tax Income
ÂĄ2.2B
CAGR 3-Years
62%
CAGR 5-Years
72%
CAGR 10-Years
N/A
No Stocks Found

Hualan Biological Engineering Inc
Glance View

Market Cap
31.8B CNY
Industry
Biotechnology

Hualan Biological Engineering Inc., nestled in the heart of China, operates at the crossroads of innovation and health, focusing primarily on the production of vaccines and blood products. The company is at the forefront of a critical industry, ensuring the creation of products that play a pivotal role in maintaining public health. With a dedicated pursuit of scientific excellence, Hualan develops vaccines that protect against contagious diseases and specializes in plasma-derived therapeutics that have become a backbone in treating a variety of conditions requiring immune support or clotting factors. This dual focus not only showcases their expertise but also broadens their commercial portfolio, tapping into markets where demand is continually rising. Revenue streams for Hualan Biological are primarily driven by their deep penetration into domestic markets, where there is a growing emphasis on healthcare innovation and quality assurance. The company capitalizes on its research and development capabilities, which have enabled it to secure a strong pipeline of products and stay ahead in a competitive landscape. By leveraging its robust distribution network and quality manufacturing processes, Hualan ensures that its products reach hospitals and health institutions rapidly. This strategic orchestration of science and logistics allows Hualan not only to generate substantial revenues but also to reinforce its reputation as a leader within China's biopharmaceutical sector, ensuring it remains a vital contributor to public health initiatives.

Intrinsic Value
25.39 CNY
Undervaluation 31%
Intrinsic Value
Price

See Also

What is Hualan Biological Engineering Inc's Pre-Tax Income?
Pre-Tax Income
1.7B CNY

Based on the financial report for Sep 30, 2024, Hualan Biological Engineering Inc's Pre-Tax Income amounts to 1.7B CNY.

What is Hualan Biological Engineering Inc's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 10Y
10%

Over the last year, the Pre-Tax Income growth was 0%. The average annual Pre-Tax Income growth rates for Hualan Biological Engineering Inc have been -8% over the past three years , and 10% over the past ten years .

Back to Top